REGENESORB: payments to doctors
Payments that named REGENESORB as the associated device or medical supply, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $168K
- Providers
- 351
- Transactions
- 446
- Average per transaction
- $376
The per-transaction average — $376 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 351 providers the average total is $478, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Smith+Nephew | $167,672 | 100.0% |